Cytotoxic to GBM cells by:– TRAIL-sensitizing effect– increasing Bim– reducing MAPKs-dependent pathway activations with GTPase activation;– suppression of ERK1/2 and Ras/PI3K/Akt pathway– Activation of JNK1/2. The gene discussed is BCL2L11; the disease is glioblastoma.